Bulletin From Annual General Meeting in Senzime AB (publ)

UPPSALA, SE / ACCESS Newswire / May 19, 2026 / Senzime (STO:SEZI) (OTCQX:SNZZF) - The annual general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the "Company") was held on 19 May 2026 at the Company's premises on Verkstadsgatan 8, Uppsala, whereby the shareholders primarily resolved on the following matters.

Annual report and results

The annual general meeting adopted the income statement and the balance sheet for the financial year 2025 and resolved, in accordance with the board of directors' proposal, that the result according to the approved income statement should be transferred to a new account. No dividends are to be paid.

Discharge from liability

The general meeting granted the members of the board of directors and the managing director discharge from liability for the management of the Company's business for the financial year 2025.

Remuneration to the board of directors and the auditor and introduction of shareholder program for board members

The annual general meeting resolved, in accordance with the nomination committee's proposal, that cash base remuneration for the period until the end of the annual general meeting 2027 shall be paid in the amount of SEK 550,000 to the chairman of the board, SEK 375,000 to the vice chairman and SEK 275,000 to each of the other members of the board of directors. Furthermore, it was resolved that remuneration for committee work shall be paid in a total amount of not more than SEK 325,000, distributed in accordance with the nomination committee's proposal. No board remuneration shall be paid to a board member who during the fiscal year 2026 receives consultancy fees from the Company exceeding a total amount equivalent to twice the cash board remuneration resolved at this annual general meeting.

The annual general meeting further resolved, in accordance with the nomination committee's proposal, to introduce Board Program 2026, a shareholder program for board members. Under the program, the chairman of the board is allocated Share Rights equivalent to SEK 550,000 and other participating board members are allocated Share Rights equivalent to SEK 275,000 each, calculated on the basis of the volume-weighted average price of the Company's share on Nasdaq Stockholm during the 10 trading days prior to the Allocation Date. The Share Rights vest after approximately one year, provided that the participant is still a board member, and thereafter entitle the holder to receive common shares free of charge. Members connected to the Segulah group and the Crafoord group, respectively, do not participate in the program. The annual general meeting also resolved to authorize the board to resolve on a directed issue of a maximum of 700,000 Class C shares, on the repurchase of issued Class C shares and on the transfer of own common shares to participants in the program, in order to ensure the delivery of shares within the framework of Board Program 2026.

Schreibe Deinen Kommentar